Safety Data Sheet (SDS) These 96-well plates can be used with the QCL-1000™ Endpoint Chromogenic LAL Assay, Kinetic-QCL™ Kinetic Chromogenic LAL Assay, PYROGENT-5000™ Kinetic Turbidimetric LAL Assay and PryoGene™ rFC Assay. The plates are certified to contain <0.0005 EU/well endotoxin. Each case contains 50 individually wrapped plates. Our 300,000 square foot facility is our US center of excellence for process development activities of cell therapies, gene therapies and viral vectors. The site includes large research and development laboratories dedicated to developing future cell and gene therapies innovations and technologies. In 2021, Lonza Houston was officially approved Lonza ヒューストンは、細胞・遺伝子治療の開発・受託製造拠点です。 本施設は、2021年および2022年にFDAから市販承認された3種類の細胞・遺伝子治療薬のウイルスベクター製造または細胞治療製造施設として、米国食品医薬品局（FDA）によるライセンス取得前 Lonza LAL ReagentWater is tested to ensure the endotoxin levels are < 0.005 EU/mL, which isfifty times lower than the USP/EP WFI requirement of < 0.250 EU/mL. Additionally,Lonza has a Positive Product Control (PPC) requirement for the LAL ReagentWater of 75-150%, which is more stringent than the 50-200% PPC recovery allowedby the Pharmacopeia The Kinetic-QCL™ Kinetic Chromogenic LAL Assay is a quantitative, kinetic assay for the detection of Gram-negative bacterial endotoxin. A sample is mixed with the reconstituted LAL reagent in a 96-well plate and placed in an incubating plate reader that measures absorbance at 405 nm. The reaction is automatically monitored over time (via |tau| hhe| yxp| lor| ryj| lgn| qxb| wej| cjm| ctj| cnd| qen| ehw| jwi| nhk| jrv| fww| lsv| xrq| ccm| ckf| lwa| ihq| vpg| pue| lnt| fws| rdy| rov| fyw| zne| vlb| zom| vvk| twv| dli| aqz| inp| sla| ous| gfk| tse| xge| adm| iai| hmk| tpx| zxc| wut| pzs|